Established Industry Presence Olerup operates within the niche biotechnology research sector, specializing in molecular diagnostic products for HLA typing and antibody detection, presenting opportunities for peripheral testing or complementary products.

Global Reach With offices in the United States and Austria, and a focus on international distribution, there is potential to expand sales channels and introduce new diagnostic solutions across diverse markets.

Parent Company Leverage As a subsidiary of CareDx Inc., a publicly traded company, Olerup can leverage its corporate backing for joint product development and access to a broader customer base in the clinical diagnostics industry.

Growing Revenue Potential With reported revenues between 10 million and 25 million dollars and a small team, there is significant room for growth in sales of molecular diagnostic products, especially targeting hospitals and research institutions.

Technology Adoption Utilizing modern web tools like Google Analytics and Concrete CMS, Olerup demonstrates a focus on digital engagement; aligning sales strategies with these digital channels can boost outreach to potential clients.